Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis

This study has been terminated.
(Change of dose regimen (new protocol))
Information provided by:
Provectus Pharmaceuticals Identifier:
First received: November 7, 2007
Last updated: July 7, 2009
Last verified: July 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)